Drug Topics September 2019

Biosimilars may need more time to devleop in the market.

Racemic substitutions for single-enantiomer drugs offer new opportunities for savings.

Biologic medicines could lower spending by $153 billion by 2023.

Psoriasis, MS, Lupus, and RA.

Some pharmacies are now serving coffee and other refreshments. 

An estimated 100 million Americans lack good access to pharmacies.

Caused by lower income, insurance status, higher prices, poor transportation, long distances.

Layoffs highlight increasing jobs problem. 

Ensuring your pharmacy’s video marketing dusts the competition has never been more important.

Programs shown to improve patient outcomes, reduce antibiotic resistance, and decrease healthcare costs.

Cost, education, self-monitoring, and more. 

Indicated as part of a three-drug oral combination.

New medications and treatment guidelines

"Community pharmacies have reasons to be optimistic..." writes Jhaveri. 

Current phase 3 studies investigative novel, preventative approaches.

New changes are making it more difficult for generics and biosimilars to compete on formularies.

Technicians, clerks, even front-end cashiers are taking on new responsibilities.

Good Neighbor Pharmacy, Sam’s Club receive top rankings.

CarePass program appeals to wide consumer audience, trial finds.

2019 cases greater than five-year trend.

More jobs in jeopardy as chains struggle to save expenses.

Independent pharmacies differentiate with service and high-touch care.

76 billion opioid pain pills distributed from 2012-2016.